1. Home
  2. UPXI vs PNNT Comparison

UPXI vs PNNT Comparison

Compare UPXI & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPXI
  • PNNT
  • Stock Information
  • Founded
  • UPXI 2018
  • PNNT 2007
  • Country
  • UPXI United States
  • PNNT United States
  • Employees
  • UPXI N/A
  • PNNT N/A
  • Industry
  • UPXI Medicinal Chemicals and Botanical Products
  • PNNT Finance: Consumer Services
  • Sector
  • UPXI Health Care
  • PNNT Finance
  • Exchange
  • UPXI Nasdaq
  • PNNT Nasdaq
  • Market Cap
  • UPXI 481.8M
  • PNNT 423.8M
  • IPO Year
  • UPXI 2021
  • PNNT 2007
  • Fundamental
  • Price
  • UPXI $3.31
  • PNNT $6.38
  • Analyst Decision
  • UPXI
  • PNNT Sell
  • Analyst Count
  • UPXI 0
  • PNNT 5
  • Target Price
  • UPXI N/A
  • PNNT $6.38
  • AVG Volume (30 Days)
  • UPXI 4.0M
  • PNNT 449.7K
  • Earning Date
  • UPXI 11-11-2025
  • PNNT 11-24-2025
  • Dividend Yield
  • UPXI N/A
  • PNNT 15.05%
  • EPS Growth
  • UPXI N/A
  • PNNT 21.65
  • EPS
  • UPXI N/A
  • PNNT 0.80
  • Revenue
  • UPXI $15,811,345.00
  • PNNT $130,923,000.00
  • Revenue This Year
  • UPXI $145.75
  • PNNT N/A
  • Revenue Next Year
  • UPXI N/A
  • PNNT N/A
  • P/E Ratio
  • UPXI N/A
  • PNNT $8.00
  • Revenue Growth
  • UPXI N/A
  • PNNT N/A
  • 52 Week Low
  • UPXI $1.90
  • PNNT $5.72
  • 52 Week High
  • UPXI $22.57
  • PNNT $7.53
  • Technical
  • Relative Strength Index (RSI)
  • UPXI 29.09
  • PNNT 37.49
  • Support Level
  • UPXI $3.44
  • PNNT $6.39
  • Resistance Level
  • UPXI $5.25
  • PNNT $6.55
  • Average True Range (ATR)
  • UPXI 0.37
  • PNNT 0.12
  • MACD
  • UPXI -0.13
  • PNNT 0.01
  • Stochastic Oscillator
  • UPXI 12.55
  • PNNT 9.38

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: